TITLE

bactam

PUB. DATE
January 2009
SOURCE
Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p229
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "bactam," which refers to a suffix used to denote an antibiotic that inhibits bacterial beta lactamase, is presented.
ACCESSION #
62135891

 

Related Articles

  • Superbugs vs superdrugs.  // India Today;5/2/2011, p38 

    The article discusses the superbug NDM-1 scare in India. NDM-1, or the New Delhi metallo-beta-lactamase, is the deadliest bacteria in the world because it is resistant to all known antibiotics. NDM-1 became an international news when British researchers reported in the journal "Lancet Infectious...

  • New metallo �-lactamase NDM-1. Raghunath, D. // Indian Journal of Medical Research;Nov2010, Vol. 132 Issue 5, p478 

    The author discusses the application of metallo �-lactamase (MBL) NDM-1. He claims that the MBL are the more versatile enzymes that are capable of converting the host bacteria into nearly total �lactam insusceptibility. He describes the properties of the NDM-1 gene. He comments on a...

  • Antibiotic-resistant infections on the rise. Schoen, John // Infectious Disease News;Apr2014, Vol. 27 Issue 4, p6 

    The article discusses a study by Steven Kassakian and Leonard Mermel, published in the March 25, 2014 issue of "Antimicrobial Resistance and Infection Control," on the rise in community-acquired and health care-associated infections due to extended-spectrum beta-lactamase-producing bacteria.

  • Acquired Metallo-�-Lactamases: An Increasing Clinical Threat. Rossolini, Gian Maria // Clinical Infectious Diseases;12/1/2005, Vol. 41 Issue 11, p1557 

    This article focuses on an increasing clinical threat to acquired metallo-�-lactamases. The production of �-lactamase was the first recognized mechanism of bacterial resistance to �-lactam antibiotics. Two different families of �-lactamases can be evolved in bacteria: the...

  • Why is the Microbiology Lab Calling About an Extended-Spectrum Beta-Lactamase Bacterium From a Wound Culture? Ribes, Julie; Rapp, Robert P. // Orthopedics;Nov2005, Vol. 28 Issue 11, p1322 

    Offers a better understanding of extended-spectrum beta-lactamases and what such a report means to the patient when a medical professional is called by the microbiology laboratory. Most common beta-lactamase enzymes produced by Escherichia coli and Klebsiella pneumoniae; Overview of...

  • Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study. Bay, Arindam; Bairy, Indira // Annals of Thoracic Medicine;Apr-Jun2007, Vol. 2 Issue 2, p52 

    BACKGROUND: Ventilator-associated pneumonia (VAP) is an important intensive care unit (ICU) infection in mechanically ventilated patients. VAP occurs approximately in 9-27% of all intubated patients. Due to the increasing incidence of multidrug-resistant organisms in ICUs, early and correct...

  • New Delhi metallo beta- Lactamase-1; Incidence and threats. D., Gayathri; Eramma, N. K.; Devaraja, T. N. // International Journal of Biological & Medical Research;May2012, Vol. 3 Issue 3, p1870 

    Carbapenems are among the few useful antibiotics against multidrug resistant Gram negative bacteria particularly those with extended spectrum beta-lactamase. Resistance to carbapenems is mediated by loss of outer membrane proteins and production of beta lactamase that is capable of hydrolyzing...

  • To the rescue of old drugs. MEZIANE-CHERIF, DJALAL; COURVALIN, PATRICE // Nature;6/26/2014, Vol. 510 Issue 7506, p477 

    The article focuses on the need for the development of new antibiotics due to emergence and spread of antibiotic resistance in bacteria. It informs about a research on aspergillomarasmine A, a naturally occurring fungal product. It mentions that the fungal compound is a potent inhibitor of...

  • Mechanisms of Resistance: Useful Tool to Design Antibacterial Agents for Drug - Resistant Bacteria. Savjani, J. K.; Gajjar, A. K.; Savjani, K. T. // Mini Reviews in Medicinal Chemistry;Feb2009, Vol. 9 Issue 2, p194 

    Drug-resistant bacteria are now a global health threat. In the last 5 years the WHO, The House of Lords (UK), the Centre for Disease Control (USA) and many more agencies have presented reports on the scale of this problem. Microorganisms multiply very rapidly and have adapted to fill almost...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics